We reported the stepwise formation of biocompatible poly(L-lysine)/poly(Lglutamic acid) (PLL/PGA) multilayer films on mesoporous silica (MS) spheres via layer-by-layer (LbL) self-assembly technique. In-situ QCM revealed the nonlinear (exponential) growth of PLL/PGA multilayer films at both pH 5.5 and pH 7.0 conditions. ξ-potential measurements of the multilayer coated particles indicated that the multilayer surface is being charge-overcompensated in each adsorption step, thereby facilitating adsorption of the next oppositely charged polypeptide onto the MS spheres. Hollow polypeptide capsules could be obtained by subsequently removing silica cores. By using enzyme-preloaded MS spheres as capsule templates, a general approach was developed for encapsulating enzymes in biocompatible microcapsules with high loading and retained bioactivity. The loading amount for several enzymes with different sizes and their bioactivity after encapsulation were also reported.
Introduction
In the last decade, the layer-by-layer (LbL) self-assembly method, which is based on the stepwise electrostatic assembly of oppositely charged species [1, 2] , has emerged as a promising and versatile approach to the fabrication of functional molecular assemblies with well-defined architectures. A great advantage offered by the LbL technique is its ability to coat substrates of various shapes and sizes with uniform layers of varying composition (e.g., polymers, biological macromolecules, dyes and nanoparticles) and the achievement of controllable thickness at a molecular scale. The geometry of the substrates is not necessarily planar but can be curved or spherical. The extension of the LbL method to colloidal particles and the subsequent removal of the template core has led to a viable alternative for preparing hollow capsules with controlled composition, wall thickness and size [3] [4] [5] , which are of great usefulness in the encapsulation of functional materials [5, 6] . More recently, the method has also been extended to the coating of multilayer films onto porous particles [7] [8] [9] [10] . For example, by employing interlayer cross-linking, multilayer films of polyelectrolytes (PEs) were successfully deposited into the pores of mesoporous silica spheres, which provides an effective way to prepare nanoporous solid PE spheres with controlled diameter and excellent capacity for immobilizing biomolecules [7] .
Sukhorukov and co-workers demonstrated that LbL coating of porous inorganic microparticles of calcium carbonate followed by core removal resulted in the matrix polyelectrolyte microcapsules which also have good capability of loading macromolecules [9, 10] .
Within the past few years, there has been increasing interests in the preparation and biomedical application of biocompatible multilayer films that constructed by natural polyelectrolytes (e.g. hyaluronan, alginate, chitosan, collagen) and
polypeptides (e.g., PLL, PGA) [11] [12] [13] [14] . For example, multilayer films of dextran/chitosan have the properties of pro-or anti-coagulation depending on the outmost layer of the film [11] . In a recent study, Picart et al reported that the cell adhesive behaviour could be controlled by the structure and architecture of PLL/PGA multilayer films, which could be tuned by varying the pH values during film preparation [13] . However, most of the previous studies on biocompatible multilayer films have been focussed on films deposited on flat substrates. It is of great interest to coat these films onto colloidal particles, as it will not only provide further insight into the deposition and layer properties of these films, but also afford a new class of colloidal particles and hollow capsules with biocompatible surfaces. In the present work, we take polypeptides PLL/PGA as example to examine the progressive coating of multilayer films onto mesoporous silica (MS) spheres via the LbL self-assembly technique. Because most of the biocompatible polymers are weak polyelectrolytes (polymers with degrees of dissociation that depend strongly on pH) and particles coated with weak polyelectrolytes easily lose their colloidal stability during the coating process [15] , buffer solutions are used to control the pH condition throughout the multilayer film coating process. We also demonstrate the preparation of hollow polypeptide capsules by subsequently removing the silica cores. Based on these studies, a general approach is developed for encapsulating biomolecules into hollow capsules with high loading and retained bioactivity by using enzyme pre-loaded MS spheres as capsule templates.
Experimental

Materials
Poly(L-lysine) hydrobromide (PLL, M W 30,000 -70,000 g mol
), poly(Lglutamic acid) (PGA, M W 50,000-100,000 g mol Milli-Q purification system and had a resistivity higher than 18 MΩ cm. 
Preparation of FITC-labelled polypeptide and enzymes
PLL/PGA microcapsule formation and enzyme encapsulation
Approximately 5 mg of bare or enzyme-loaded MS particles (see Table 1 for detailed adsorption conditions used for different enzymes) were added to 1 mg mL 
Characterization
ζ-potentials were measured on a Zetasizer 2000 (Malvern) instrument.
Transmission electron microscopy (TEM) samples were prepared by placing a drop of
a diluted suspension (dispersed in water) onto a TEM grid and were measured on a Philips CM 120 microscope operated at 120 kV. Confocal laser scanning microscopy (CLSM) images were taken with an Olympus confocal system equipped with a 60x oil immersion objective.
Results and discussion
PLL/PGA multilayer film assembly
In order to gain a better understanding of the multilayer deposition process, in-situ QCM experiments were first conducted to examine the formation of PLL/PGA films on planar supports. in the QCM frequency is observed, indicating the successful formation of a PGA/PLL multilayer film at both pH conditions. However, unlike the normal polyelectrolyte multilayer films with linear thickness and mass growth, PLL/PGA multilayer films exhibit a nonlinear mass growth, i.e. the material adsorbed on the electrode increases more than linearly with the number of deposited layers. This nonlinear or exponential growth of the film was also observed previously in the formation of PLL/PGA films on other substrates [13, 18, 19] and in films comprising PLL or PGA, for example, PLL/hyaluronic acid [20] and PGA/poly(allylamine hydrochloride) [21] multilayer films. Previous studies on polyelectrolyte LbL multilayer films have demonstrated that the growth of the multilayer film is entropy driven and an endothermic complexation process of PLL/PGA corresponds to the exponential growth of the film [22] . The high mobility of the polymers that comprise the film, i.e., the diffusion in
and out of PGA and/or PLL of the whole film during each deposition step, is also believed to contribute to the exponential growth [23, 24] . The larger increase of ΔF during PLL injection indicates that PGA is the main diffusing species. As the diffusion of PGA (PI ~3.5) is more favourable at pH 5.5 than pH 7 due to lower charge density, the nonlinear growth of the film becomes more pronounced at pH 5.5.
PLL/PGA multilayer film assembly on MS spheres
The PLL/PGA layers were then deposited onto MS spheres by using the same The build-up of the PLL/PGA multilayer on MS particles is then characterized by TEM. Figure 3a shows the TEM image of bare MS spheres which have a particle size ranging from 2-4 µm. At higher magnification (Figure 3a, inset) , the disordered porous structure becomes apparent. Figure 3b shows the low and high (inset) magnification TEM image of MS particles after three-bilayer PLL/PGA coating.
Compared with uncoated MS particles (Figure 3a) , the polypeptide coated particles show a higher electron density on the shell, indicating that the polypeptide coating lies on the particle surface as well as to some extent in the mesopores due to the permeation of polypeptide chains into the mesopores [7] . The formation of the shrinkage or breakage of the capsules was observed indicates that the three-bilayer PLL/PGA coating is rather stable during the silica core dissolution process.
Enzyme encapsulation in PLL/PGA microcapsules
We have shown the successful formation of PLL/PGA multilayer films on MS spheres and the resultant PLL/PGA capsules by removing the silica templates. If we coat the multilayer film on enzyme preloaded MS spheres, we should be able to directly encapsulate enzymes into PLL/PGA microcapsules. The MS spheres used have a bimodal pore structure (small pores of 2-3 nm and large pores of 10-40 nm), a surface area of 630 m 2 g -1 and a pore volume of 1.72 mL g -1 [25] [26] [27] [28] . The ability of the MS spheres for immobilizing enzymes with different sizes is shown in Table 1 for different enzymes which is mainly dependent on how strong enzyme molecules adsorb on silica. If the interaction between enzyme and MS is weaker than the interaction between enzyme and PLL, the enzyme molecules tend to desorb from the MS spheres resulting in a reduced loading amount in capsule. For example, the loading amount of POD in 1g MS spheres is 150 mg which is double the loading amount of catalase. However, when exposed to PLL, due to the very weak interaction between POD and silica, nearly 90% of the POD molecules desorb from the MS spheres while very few catalase desorption is observed, which resulted in the final loading amount of POD in the capsules being much less than that of catalase (Table 1) .
It should be noted that this is the main step in which the loaded enzyme is lost. After forming the PLL layer, the PLL coating network blocks the mesopores and provides Table 1, varies greatly for different enzymes (see discussions above). The high enzyme loading, particularly for large enzymes (>10 nm) that are difficult to load into pre-formed hollow capsules is noteworthy.
It is important that the encapsulated enzymes can survive the HF treatment and keep their biological activity. We thus take urease as an example to measure the activity after encapsulation. Urease is an enzyme that catalyzes the hydrolysis of urea.
The activity of urease can be quantitatively examined by a pH-sensitive dye (phenol red) in a mixed buffer solution containing urea, according to a standard procedure [30] . The activity of urease in the PLL/PGA microcapsules is measured to be ~49% of its original value in solution. This decrease in bioactivity is mainly due to the diffusion limitations in the enzymatic reaction, which typically happens when
enzymes are in an immobilized state [26, 28, 31] . However, compared with some recent reports on urease immobilization, for example, urease immobilized in halloysite nanotube (~17%) [32] and urease post-infiltrated in poly(allylamine hydrochloride)/poly(styrene sulfonate) capsules (~13%) [33] , this activity value is still much higher, which we attribute to that urease is largely in a free state in the microcapsules. The results also suggest that the HF buffer used for silica dissolution does not significantly decrease the enzymatic activity. In addition, it should be mentioned that although the enzyme activity decreases after encapsulation, the encapsulated enzyme showed an enhanced lifetime and reaction stability than the free enzyme in solution. Our recent study also showed that the urease-loaded microcapsules could act as biomimetic reactors to precipitate calcium carbonate exclusively in the capsule interior [28] .
Conclusions
In summary, we have demonstrated the successful formation of biocompatible PLL/PGA multilayer films both on planar substrates and mesoporous silica spheres by means of in-situ QCM, ξ-potential, TEM and confocal microscopy characterization.
The PLL/PGA multilayer films exhibit nonlinear growth at both pH 7.0 and 5.5
conditions, which is due to the diffusion in and out of PGA and/or PLL of the whole film during each deposition step. By using enzyme-preloaded MS spheres as the capsule template and following silica dissolution, the current method provides an effective way to encapsulate various enzymes in biocompatible microcapsules with high loading and retained activity. Our recent study also showed that the encapsulated enzyme could be readily released by altering the polyelectrolyte shell permeation via changing solution pH or salt concentration [27] . Due to the immobilization capacity of mesoporous silica for various materials and the biocompatibility as well as the easy 
